Frontlight ResearchEarly access
Childhood cancers trials in Belgium
85 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Active, not recruitingA Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Where
- Gent
- Age
- 1 month to 17 years
- People
- 50 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06941272 · EU 2024-518771-66-00 - Phase 1/2Taking peopleA Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
- Where
- Leuven
- Age
- 12 years and over
- People
- 359 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT05118789 · EU 2024-511793-71-00 - Phase 2Taking peopleA Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
- Where
- Gent, Leuven, Sint-Lambrechts-Woluwe
- Age
- 1 year to 17 years
- People
- 100 worldwide
- Run by
- Pfizer
See details and how to joinNCT05748171 · EU 2023-509810-13-00 - Phase 3Taking peopleCHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML)
- Where
- Brussels, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Age
- Up to 64 years
- People
- 675 worldwide
- Run by
- Prinses Maxima Centrum voor Kinderoncologie B.V.
See details and how to join2023-504999-25-00 - Phase 2Taking peopleLong-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies
- Where
- Leuven
- People
- 1,500 worldwide
- Run by
- Kite, A Gilead Company
See details and how to joinNCT05041309 · EU 2023-507041-28-00 - Phase 1/2Taking peopleA Phase 1/2 study of Enzomenib (DSP-5336) in Patients with Acute leukemia
- Where
- Antwerp, Gent, Leuven, Roeselare
- People
- 94 worldwide
- Run by
- Sumitomo Pharma America Inc.
See details and how to join2022-502741-10-00 - No phaseTaking peoplePain and Sleep Disturbances in Children Living Beyond Cancer: A Case-Control Study
- Where
- Brussels, Jette
- Age
- 6 years to 12 years
- People
- 76
- Run by
- Vrije Universiteit Brussel
See details and how to joinNCT07120646 - Phase 3Taking peopleAn international trial for children with atypical teratoid/rhabdoid tumours (ATRT)
- Where
- Brussels, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Age
- Up to 17 years
- People
- 301 worldwide
- Run by
- GPOH gGmbH
See details and how to join2022-501456-28-00 - Phase 3Taking peopleSIOP RANDOMET 2017
- Where
- Brussels, Edegem, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Age
- Up to 17 years
- People
- 409 worldwide
- Run by
- GPOH gGmbH
See details and how to join2023-508926-91-00 - Phase 3Taking peopleSIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years.
- Where
- Brussels, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Age
- Up to 64 years
- People
- 311 worldwide
- Run by
- The University Of Birmingham
See details and how to join2024-510578-25-00 - Phase 2/3Active, not recruitingAllogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
- Where
- Brussels, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Age
- 1 month to 18 years
- People
- 1,800 worldwide
- Run by
- St. Anna Kinderkrebsforschung
See details and how to joinNCT01949129 · EU 2024-512657-24-00 - No phaseTaking peopleRegister With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed
- Where
- Leuven
- People
- 125
- Run by
- Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT01617382 - No phaseTaking peopleCerebellar Mutism Syndrome Study
- Where
- Leuven
- Age
- Up to 18 years
- People
- 2,000 worldwide
- Run by
- Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT02300766 - No phaseTaking peopleAMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE)
- Where
- Antwerp, Brussels, Leuven, Liège, Montegnée
- Age
- 3 years to 14 years
- People
- 275 worldwide
- Run by
- Erasme University Hospital
See details and how to joinNCT02595255 - Phase 3Taking peopleA Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
- Where
- Brussels, Edegem, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Age
- 0 years to 45 years
- People
- 6,430 worldwide
- Run by
- Mats Heyman
See details and how to joinNCT04307576 · EU 2022-501050-11-01 - Phase 2Taking peopleA Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Where
- Brussels, Ghent
- Age
- 1 year to 39 years
- People
- 105 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05999994 - No phaseTaking peopleHealth Effects of CArdiac FluoRoscopy and MOderN RadIotherapy in PediatriCs - Radiotherapy
- Where
- Leuven
- Age
- Up to 22 years
- People
- 2,670 worldwide
- Run by
- Institut National de la Santé Et de la Recherche Médicale, France
See details and how to joinNCT04746729 - No phaseTaking peopleSecuring Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults
- Where
- Antwerp, Brussels, Ghent, Leuven, Liège
- Age
- 0 years to 25 years
- People
- 1,600
- Run by
- Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT07727694 - Phase 1Not yet taking people in BelgiumA Study to Assess Adverse Events and How Pivekimab Sunirine Moves Through the Body of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Where
- Gent
- Age
- Up to 17 years
- People
- 18 worldwide
- Run by
- AbbVie Deutschland GmbH & Co. KG
See details and how to join2024-520125-36-00 - Phase 3Taking peopleBrentuximab Vedotin in Early Stage Hodgkin Lymphoma
- Where
- Antwerp, Edegem, Leuven, Namur, Roeselare
- Age
- 16 years to 69 years
- People
- 1,042 worldwide
- Run by
- University College, London
See details and how to joinNCT04685616 · EU 2022-500031-37-00 - No phaseTaking peopleSPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
- Where
- Aalst, Antwerp, Brussels, Ghent, Haine-Saint-Paul, Leuven, Liège, Namur, Turnhout, Yvoir
- Age
- 12 years and over
- People
- 4,975 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT02834884 - Phase 2/3Taking peopleSIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependymoma
- Where
- Brussels, Edegem, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Age
- Up to 64 years
- People
- 894 worldwide
- Run by
- Centre Leon Berard
See details and how to joinNCT02265770 · EU 2024-512222-28-00 - Phase 1/2CompletedA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Leuven
- Age
- 12 years and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - No phaseEnrolling by invitationComparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.
- Where
- Leuven
- Age
- 28 days and over
- People
- 1,600
- Run by
- prof. dr. Koen Van Laere
See details and how to joinNCT07595666 - Phase 3Taking peopleInternational Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
- Where
- Brussels, Edegem, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Age
- Up to 18 years
- People
- 683 worldwide
- Run by
- University Hospital Muenster
See details and how to joinNCT04043494 · EU 2023-508101-24-00